Tilray Brands, Inc. (2HQ0)
Summary
2HQ0 Chart
BrewDog Acquisition Boosts Tilray's Q1 Performance
Tilray reported Q1-2027 financial results last week with increasing revenue from its BrewDog operations; Cannabis revenue decreased. The company expects its new beer assets along with its international cannabis operations to continue to drive growth. The company reported a net loss and negative free cash flow.
Tilray Q1: Not Looking Good, Remains A 'Hold'
Tilray reported disappointing fiscal Q1 results, missing revenue estimates despite management highlighting record sales. TLRY's revenue growth was driven solely by the BrewDog acquisition; core cannabis sales declined 13%, and the adjusted bottom line swung to a loss. Cash burn surged to $23.4 million, and share dilution remains severe, with shares outstanding up over 31% year-over-year.
Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript
Tilray Brands, Inc. (2HQ0) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Tilray Brands, Inc. ever had a stock split?
Tilray Brands, Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Irwin David Simon CEO | XHAN Exchange | US88688T2096 ISIN |
| CA Country | 3,595 Employees | - Last Dividend | 2 Dec 2025 Last Split | - IPO Date |
Overview
Tilray Brands, Inc. is a diversified lifestyle consumer products company with a global presence, engaging in the research, cultivation, processing, and distribution of medical cannabis products. Its operations span across Canada, the United States, Europe, Australia, New Zealand, Latin America, and other international regions. The company's business is segmented into Beverage Alcohol, Cannabis, Distribution, and Wellness, reflecting its broad range of activities in the industry. Tilray Brands, Inc. underwent a rebranding from its former name, Tilray, Inc., to its current designation in January 2022, signaling a strategic shift or expansion in its business model. The corporate headquarters is situated in Leamington, Canada, positioning it strategically in one of Canada's prime agricultural and industrial hubs.
Products and Services
The comprehensive portfolio of Tilray Brands, Inc. spans across various sectors including cannabis, beverage alcohol, wellness products, and more, catering to both the medical and recreational markets:
- Medical and Adult-Use Cannabis Products: Employs rigorous cultivation and processing methods to ensure high-quality products for both medical patients and adult consumers.
- Pharmaceutical and Wellness Products: Includes the procurement and resale of these items, targeting various wellness needs beyond cannabis.
- Beverage Alcohol Products: Encompasses the production, marketing, sale, and distribution of a diverse range of alcoholic drinks.
- Hemp-Based Food and Other Wellness Products: Offers an array of hemp-derived consumables and wellness goods, capitalizing on the growing demand for these healthy alternatives.
Renowned for its brand diversity, Tilray operates under multiple well-recognized names in the industry, such as Tilray, Aphria, Broken Coast, and Charlotte's Web, amongst others. The brands cover a wide spectrum from beverage alcohol (Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, etc.) and wellness products (Manitoba Harvest, CC Pharma) to a variety of cannabis-related offerings (Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF). Furthermore, the company has extended its portfolio through acquisitions and partnerships, exemplified by names like HEXO, Alpine Beer Company, Green Flash, and Redhook Brewery. Tilray's strategic approach involves not just producing and selling, but also engaging in direct-to-consumer sales and leveraging relationships with retailers, wholesalers, healthcare professionals, and governmental bodies globally.
Contact Information
